| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/27/2011 | US20110020229 Multi-Component Biological Transport Systems |
| 01/27/2011 | US20110020227 Polysaccharide-containing block copolmer particles and uses thereof |
| 01/27/2011 | US20110020226 Particle structures comprising sterols and saponins |
| 01/27/2011 | US20110020222 Modified antibodies and methods of use |
| 01/27/2011 | DE102010027315A1 Verfahren zur Entwicklung einer als Schaum auf die Haut zu applizierende flüssige Zusammensetzung sowie eine topisch applizierbare Zusammensetzung A process for the development of a foam on the skin as a liquid composition to be applied, and a topically applicable composition |
| 01/27/2011 | CA2770517A1 Cyclosporin conjugates |
| 01/27/2011 | CA2768668A1 Galantamine amino acid and peptide prodrugs and uses thereof |
| 01/27/2011 | CA2768598A1 Delivery system and conjugates for compound delivery via naturally occurring intracellular transport routes |
| 01/27/2011 | CA2768547A1 E-polylysine conjugates and use thereof |
| 01/27/2011 | CA2768494A1 Methods of treating her2 positive cancer with her2 receptor antagonist in combination with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin |
| 01/27/2011 | CA2768457A1 Pharmaceutical compositions |
| 01/27/2011 | CA2768392A1 Oligomer-opioid agonist conjugates |
| 01/27/2011 | CA2768024A1 A stable pharmaceutical omeprazole formulation for oral administration |
| 01/27/2011 | CA2761600A1 Fentanyl-containing adhesive preparation for external use |
| 01/27/2011 | CA2708848A1 Method for preparing porous collagen matrices |
| 01/26/2011 | EP2278004A1 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 01/26/2011 | EP2277890A1 Peptide capable of extending half-life of peptide of interest in plasma |
| 01/26/2011 | EP2277551A2 Cyclodextrin-based polymers for delivering the therapeutic agents covalently bound thereto |
| 01/26/2011 | EP2277550A1 Conjugated biological molecules and their preparation |
| 01/26/2011 | EP2277549A2 Therapeutic polyanhydride compounds for drug delivery |
| 01/26/2011 | EP2277548A2 Magnetic nanoparticles linked to a ligand |
| 01/26/2011 | EP2277547A1 Epsilon-polylysine conjugates and their utilisation |
| 01/26/2011 | EP2277546A1 Stable ready to use injectable paracetamol formulation |
| 01/26/2011 | EP2277545A1 Particle with inducible shape alteration |
| 01/26/2011 | EP2277544A1 Biocompatible magnetic nano-clusters containing iron oxide respectively iron oxide - boron with primary use in magnetic drug targeting and boron neutron capture therapy |
| 01/26/2011 | EP2277542A1 Modified antibodies to prostrate-specific membrane antigen and uses thereof |
| 01/26/2011 | EP2277521A1 Tamper-resitant oral opioid agonist formulations |
| 01/26/2011 | EP2277517A1 Nateglinide tablet composition |
| 01/26/2011 | EP2277507A1 Method of producing a cationic liposomal preparation comprising a lipophilic compound |
| 01/26/2011 | EP2276727A1 Methods and compositions comprising novel cationic lipids |
| 01/26/2011 | EP2276511A2 Compositions and methods for delivering inhibitory oligonucleotides |
| 01/26/2011 | EP2276510A2 Chemical and biochemical adducts as biomarkers for organophosphate exposure |
| 01/26/2011 | EP2276506A1 Potent conjugates and hydrophilic linkers |
| 01/26/2011 | EP2276470A2 Alpha adrenergic receptor agonists for treatment of pain and/or inflammation |
| 01/26/2011 | EP2276468A2 Demulsifiers and methods for use in pharmaceutical applications |
| 01/26/2011 | EP2276467A2 Alpha and beta adrenergic receptor agonists for treatment of pain and/or inflammation |
| 01/26/2011 | EP2276464A2 Combinations of antiviral agents and other compounds |
| 01/26/2011 | EP2276463A2 Diterpene glycosides as natural solubilizers |
| 01/26/2011 | EP2276462A1 Ophthalmic solutions displaying improved efficacy |
| 01/26/2011 | EP2276458A1 Liquid buffered gdf-5 formulations |
| 01/26/2011 | EP2026815B1 Controlled released preparations of oxcarbazepine having sigmoidal release profile |
| 01/26/2011 | EP1660513B1 A ca6 antigen-specific cytotoxic conjugate and methods of using the same |
| 01/26/2011 | EP1581649B1 Binding agents which inhibit myostatin |
| 01/26/2011 | CN201719567U Gradient slow-release structure of antitubercular medicine |
| 01/26/2011 | CN1980761B Metal fine particle, method for producing metal fine particle, composition containing same, optical absorbing material and application thereof |
| 01/26/2011 | CN1947721B Method for preparing epirubicin slow-release prepn |
| 01/26/2011 | CN1713888B Cream for treatment of skin injured by the sun |
| 01/26/2011 | CN101959534A Enzyme and receptor modulation |
| 01/26/2011 | CN101959532A Pharmaceutical composition for transnasal administration |
| 01/26/2011 | CN101959520A Fluocinolone formulations in a biodegradable polymer carrier |
| 01/26/2011 | CN101959519A Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection |
| 01/26/2011 | CN101959503A Liposome for delivery to posterior segment of eye and pharmaceutical composition for disease in posterior segment of eye |
| 01/26/2011 | CN101959501A Stabilized single-liquid pharmaceutical composition containing docetaxel |
| 01/26/2011 | CN101959500A Aqueous pharmaceutical compositions containing borate-polyol complexes |
| 01/26/2011 | CN101955571A Method for preparing rosin-based polymer microspheres |
| 01/26/2011 | CN101955543A Nerve growth factor bound with laminin, and coding gene and application thereof |
| 01/26/2011 | CN101955515A Progesterone releasing hormone-methotrexate compound and pharmaceutical application thereof |
| 01/26/2011 | CN101954095A Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells |
| 01/26/2011 | CN101954091A Reducible and degradable polymer pre-medicament and preparation method thereof |
| 01/26/2011 | CN101954090A Dihydroartemisinin beta-cyclodextrin inclusion compound, preparation method thereof and antimalarialdrug with same |
| 01/26/2011 | CN101954089A Animal medicine inclusion compound, preparation method and application thereof |
| 01/26/2011 | CN101954088A Preparation method of medicine-carrying nano particle provided with specific identification radical on surface |
| 01/26/2011 | CN101954087A Fucoidan medicinal carrier and preparation method thereof |
| 01/26/2011 | CN101954086A Waterborne enteric coating powder as well as preparation and using methods thereof |
| 01/26/2011 | CN101954085A Method for preparing magnetic-targeted thermochemotherapy gold shell nano-drug delivery system |
| 01/26/2011 | CN101954076A Immunotherapy and prevention of autoimmune hepatitis |
| 01/26/2011 | CN101954073A Novel anti-tumor cell vaccine and preparation method thereof |
| 01/26/2011 | CN101954067A Aqueous solution of recombinant human serum albumin-interferon alpha fusion protein and preparation method thereof |
| 01/26/2011 | CN101954066A Medicament for promoting repair of peripheral nerve injury |
| 01/26/2011 | CN101954065A Recombinant human endostatin nanoparticle composition for injection and preparation method thereof |
| 01/26/2011 | CN101954001A Traditional Chinese medicinal pills for treating coronary disease and angina pectoris, preparation method thereof and detection method thereof |
| 01/26/2011 | CN101954000A Traditional Chinese medicinal dispersible tablets treating coronary disease and angina pectoris, preparation method thereof and detection method thereof |
| 01/26/2011 | CN101953953A Medicinal preparation for preventing and treating prostatic hypertrophy and preparation method thereof |
| 01/26/2011 | CN101953919A Alligator oil scald-burn cream and preparation method thereof |
| 01/26/2011 | CN101953889A Compound ceftiofur suspension emulsion injection and preparation method thereof |
| 01/26/2011 | CN101953882A Compound microcapsule for treating bacterial disease of livestock and poultry and preparation method thereof |
| 01/26/2011 | CN101953857A Compound fermented cordyceps sinensis bacterium powder (paecilomyces hepiali Cs-4 bacterium powder) composite medicine |
| 01/26/2011 | CN101953856A Lecithin soft capsule |
| 01/26/2011 | CN101953852A Antithrombin preparation and preparation method thereof |
| 01/26/2011 | CN101953837A Felodipine sustained-release tablets and preparation method thereof |
| 01/26/2011 | CN101953833A Slowly-controlled release formulation containing rizatriptan benzoate, preparation method and application thereof |
| 01/26/2011 | CN101953832A Oral drug composite of beta-cyclodextrin edaravone inclusion and preparation method thereof |
| 01/26/2011 | CN101953823A Antibacterial fishing medicament and processing method thereof |
| 01/26/2011 | CN101953822A Venlafaxine hydrochloride controlled release tablets and preparation method thereof |
| 01/26/2011 | CN101953819A Improved transdermal delivery system for administration of rotigotine |
| 01/26/2011 | CN101953818A Intranasal administration encapsulated based on polyelectrolyte capsule |
| 01/26/2011 | CN101953816A Medicinal hollow capsules and preparation method and manufacturing equipment thereof |
| 01/26/2011 | CN101953815A Soft capsule and capsule shell composition containing combined antioxidants, capsule shell and soft capsule therefrom and a preparation method thereof |
| 01/26/2011 | CN101953814A Febuxostat solid preparation |
| 01/26/2011 | CN101953813A Fibrauretin effervescent tablet as well as preparation method and detecting method thereof |
| 01/26/2011 | CN101953812A Lansoprazole enteric coated tablet and preparation method thereof |
| 01/26/2011 | CN101953810A Breviscapine pill |
| 01/26/2011 | CN101953809A Glimepiride dispersing tablet as well as preparation method and detection method thereof |
| 01/26/2011 | CN101953808A Antineoplastic compound deacetylase fungus epoxy ethyl ester injection and preparation method thereof |
| 01/26/2011 | CN101953807A Mycophenolate mofetil lyophilized powder injection for injection and preparation method thereof |
| 01/26/2011 | CN101953804A Shell layer dropping type nanometer medicine carrier preparation based on amphiphilic block copolymer and preparation method thereof |
| 01/26/2011 | CN101953802A Lansoprazole enteric preparation and preparation method thereof |
| 01/26/2011 | CN101953801A Preparation method of core/shell structure nano-particle multi-drug administrating system capable of procedurally controlling administration |
| 01/26/2011 | CN101953798A Spray drying sustained-release liquid crystal nano particles containing paeonol and preparation thereof |
| 01/26/2011 | CN101953797A Method for preparing medicament carrying controlled-release nanometer material and application |